LB PHARMACEUTICALS INC
LB-102, a benzamide antipsychotic therapeutic for neuropsychiatric disorders
- Sector
- Biotech
- Headquarters
- NEW YORK, NY
- Founded
- 2015
- Latest Form D
- $70.7M, Sep 2023
- Total capital
- $91.7M
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- $91.7M
- 9 Form D · last Sep 2023
- 37 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 7
- 25 pending · first 2019
- Rank in peer group#213 of 1449
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 9th filing$70.7M
- Private capital raisedForm D · SEC · 8th filing$6.9M
- Private capital raisedForm D · SEC · 7th filing$903K
- Private capital raisedForm D · SEC · 6th filing$4.6M
- Private capital raisedForm D · SEC · 5th filing$6.3M
- Private capital raisedForm D · SEC · 4th filing$443K
- Private capital raisedForm D · SEC · 3rd filing$330K
- Private capital raisedForm D · SEC · 2nd filing$462K
- Private capital raisedForm D · SEC · 1st filing$969K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 1449 peers
Line = medianBiotech · Molecule
- Granted patents#213 · top 15%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
Researcher links verified by same-company patents and grants- Andrew VainoResearcherExecutive OfficerLinked by 5 patents
- Anna EramoExecutive OfficerNamed in SEC Form D filings
- Chen YuDirectorNamed in SEC Form D filings
- Edmund SullivanDirectorNamed in SEC Form D filings
- Lauren StippExecutive OfficerNamed in SEC Form D filings
- Marc PanoffExecutive OfficerNamed in SEC Form D filings
Show all 15 people
- Mark PanoffExecutive OfficerNamed in SEC Form D filings
- Piero PoliDirectorNamed in SEC Form D filings
- Rajul JainDirectorNamed in SEC Form D filings
- Ran NussbaumDirectorNamed in SEC Form D filings
- Rebecca LuseDirectorNamed in SEC Form D filings
- Robert RuffoloDirectorNamed in SEC Form D filings
- Simon BasseynDirectorNamed in SEC Form D filings
- Vincent GrattanDirectorNamed in SEC Form D filings
- Zachary PrenskyExecutive Officer, DirectorNamed in SEC Form D filings
What it has protected
USPTO · 7 granted of 32- PendingUses Of Anti-psychotic AgentsUSPTOApplication 19574114
- GrantedPsychotropic Agents And Uses ThereofUSPTOUS 12,060,327
- PendingPsychotropic Agents And Uses ThereofUSPTOApplication 18335877
Show all 32 patent records
- Uses Of Anti-psychotic AgentsAug 6, 2026 · Application 19574114Pending
- Psychotropic Agents And Uses ThereofAug 13, 2024 · US 12,060,327Granted
- Psychotropic Agents And Uses ThereofMay 16, 2024 · Application 18335877Pending
- Psychotropic Agents And Uses ThereofApr 11, 2024 · Application 18516614Pending
- Psychotropic Agents And Uses ThereofAug 1, 2023 · US 11,713,295Granted
- Psychotropic Agents And Uses ThereofJul 5, 2022 · US 11,377,421Granted
- Psychotropic Agents And Uses ThereofJun 22, 2021 · US 11,040,943Granted
- Psychotropic Agents And Uses ThereofJun 23, 2020 · US 10,689,338Granted
- Psychotropic Agents And Uses ThereofMar 12, 2020 · Application 16383933Pending
- Psychotropic Agents And Uses ThereofApr 16, 2019 · US 10,259,786Granted
- Psychotropic Agents And Uses ThereofJan 1, 2019 · US 10,167,256Granted
- Psychotropic Agents And Uses ThereofApplication 63775895Pending
- Psychotropic Agents And Uses ThereofApplication 63742800Pending
- Uses Of Anti-psychotic AgentsApplication PCTUS2024050260Pending
- Uses Of Anti-psychotic AgentsApplication 63588687Pending
- Psychotropic Agents And Uses ThereofApplication PCTUS2022029900Pending
- Psychotropic Agents And Uses ThereofApplication 63189905Pending
- Potential Schizophrenia TreatmentApplication 62734974Pending
- Psychotropic Agents And Uses ThereofApplication PCTUS2017063529Pending
- Psychotropic Agents And Uses ThereofApplication 62508263Pending
- Psychotropic Agents And Uses ThereofApplication PCTUS2026010511Pending
- Psychotropic Agents And Uses ThereofApplication 62427062Pending
- Psychotropic Agents And Uses ThereofApplication 63945301Pending
- Psychotropic Agents And Uses ThereofApplication 63944361Pending
- Psychotropic Agents And Uses ThereofApplication 63939867Pending
- Psychotropic Agents And Uses ThereofApplication 63930542Pending
- Psychotropic Agents And Uses ThereofApplication 63921080Pending
- Psychotropic Agents And Uses ThereofApplication 63894542Pending
- Psychotropic Agents And Uses ThereofApplication 63875974Pending
- Psychotropic Agents And Uses ThereofApplication 63847921Pending
- Psychotropic Agents And Uses ThereofApplication 63809991Pending
- Psychotropic Agents And Uses ThereofApplication 63801019Pending
Related companies, and why
- Oncotelic Therapeutics, Inc.Similar federal contract value in Biotech · null in contracts
- Allarity Therapeutics, Inc.Similar federal contract value in Biotech · null in contracts
- Lakewood-Amedex, Inc.Similar federal contract value in Biotech · null in contracts
- Mebias Discovery, Inc.Similar federal contract value in Biotech · null in contracts
- OcuTerra Therapeutics, Inc.Similar federal contract value in Biotech · null in contracts
- Ratio Therapeutics, Inc.Similar federal contract value in Biotech · null in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .